English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In the last few years some of the biggest ‘blockbuster drugs’, that is the drugs that make pharmaceutical companies billions of dollars, have lost their patents. This means that generic manufacturers are able to produce these medications at a fraction of the cost. But what really differentiates generics from brand name medications? This commentary will explore how differences in licensing affect drug efficacy and how the pharmaceutical landscape in Canada affects patient care. RESUME Au cours des dernieres annees, les brevets de certains des plus grands « medicaments vedettes», c’est-a-dire des medicaments qui rapportent des milliards de dollars aux compagnies pharmaceutiques, sont arrives a echeance. Cela signifie que les fabricants de medicaments generiques peuvent desormais produire ceux-ci a moindre cout. Mais qu’est-ce qui differencie veritablement les me- dicaments generiques de ceux d’origine? Ce commentaire examinera comment les differences en ce qui a trait aux licences affectent l’efficacite des medicaments, et comment le panorama pharmaceutique au Canada affecte les soins de sante.

Is Brand Name Best? Brand name versus generic pharmaceuticals in clinical practice